Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Countries like India are also witnessing regulatory progress, illustrated by the approval of Novo Nordisks Wegovy in June 2025 for chronic weight management in adults, reflecting the expanding global accessibility of GLP-1 therapies
In addition, given the number of cytokines and timepoint comparisons, our biomarker analyses are subject to multiplicity and were not adjusted for multiple comparisons
Weight changes: Do not expect dramatic weight loss in the first month at 2.5mg
Additionally, it has received approval for the prevention and management of cardiovascular events in adults with type 2 diabetes and also those having existing cardiovascular disease
US$ 23.12
US$ 26.23
US$ 25.00
US$ 20.71
US$ 25.84
US$ 24.82
